Login
$ADPT
$27.87 +$0.00 (0.0%) After hours

$ADPT SEC Filings

Filed On Filing
13 Nov 2026 Form 4: Rubinstein Julie, President and COO

Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($366K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more

13 Nov 2026 Form 4: Bobulsky Susan, Chief Commercial Officer, MRD

Sold 1,875 shares ($60K)

12 Nov 2026 Form 4: Robins Chad M, Director

Gave 100,000 shares as a gift

12 Nov 2026 144
12 Nov 2026 144
10 Nov 2026 Form 4: Rubinstein Julie, President and COO

Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($358K) · Received 11,881 shares by exercise or conversion ($144K) · 1 more

06 Nov 2026 Form 4: Rubinstein Julie, President and COO

Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($313K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more

04 Nov 2026 10-Q
04 Nov 2026 8-K: Results of Operations and Financial Condition

SEATTLE, Nov. 04, 2026 (GLOBE NEWSWIRE) – Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into c...

03 Nov 2026 Form 4: Rubinstein Julie, President and COO

Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($318K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more

29 Oct 2026 Form 4: Rubinstein Julie, President and COO

Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($324K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more

26 Oct 2026 Form 4: Rubinstein Julie, President and COO

Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($291K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more

21 Oct 2026 Form 4: Rubinstein Julie, President and COO

Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($286K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more

16 Oct 2026 Form 4: Rubinstein Julie, President and COO

Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($305K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more

13 Oct 2026 Form 4: Rubinstein Julie, President and COO

Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($314K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more

08 Oct 2026 Form 4: Rubinstein Julie, President and COO

Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($330K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more

08 Oct 2026 Form 4: Bobulsky Susan, Chief Commercial Officer, MRD

Sold 6,444 shares ($193K)

06 Oct 2026 144
05 Oct 2026 Form 4: Rubinstein Julie, President and COO

Received 11,881 shares by exercise or conversion ($144K) · Sold 11,881 shares ($333K) · Received 11,881 shares by exercise or conversion ($144K) · 3 more

05 Oct 2026 Form 4: Lo Francis, Chief People Officer

Received 26,792 shares by exercise or conversion ($182K) · Sold 26,792 shares ($758K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support